Auditory Outcome after Cochlear Implantation in Children with DFNB7/11 Caused by Pathogenic Variants in TMC1 Gene

Introduction: Non-syndromic hereditary hearing loss is characterized by extreme genetic heterogeneity. So far, more than 100 pathogenic or likely pathogenic variants in TMC1 gene have been reported in patients with autosomal recessive hearing loss (HL) DFNB7/11. The prevailing auditory phenotype of individuals with DFNB7/11 is congenital, profound, bilateral HL, but the functional outcome after cochlear implantation (CI) described in the literature is variable. The objective of this work is to evaluate the auditory outcome after CI in pediatric patients with DFNB7/11, born to non-consanguineous parents. Methods: A retrospective analysis of genetic and audiological data of DFNB7/11 patients followed up in a single Italian otolaryngology clinic was performed. Cases with biallelic pathogenic variants in TMC1 were selected from the cohort of children with non-syndromic hearing loss who had undergone CI and had been molecularly characterized by multigene panel testing. All patients underwent extensive audiological assessment, and the auditory outcome after CI was evaluated. Results: DFNB7/11 was diagnosed in a total of 3 patients from 2 non-consanguineous families; a novel disease-causing variant in TMC1 was detected [c.962G>A p.(Trp321*)]. All the affected children showed the typical DFNB7/11 phenotype characterized by prelingual, severe-to-profound HL. The patients showed an excellent functional outcome after CI; speech perception, nonverbal cognition, and speech performance were comparable to those of patients with DFNB1 deafness. Discussion/Conclusion: Our results do not support the variable auditory outcome reported in the literature, which may be affected by several social and environmental factors and by the genetic background.

[1]  B. Choi,et al.  The molecular etiology of deafness and auditory performance in the postlingually deafened cochlear implantees , 2020, Scientific Reports.

[2]  Ameen Softah,et al.  Identification of TMC1 as a relatively common cause for nonsyndromic hearing loss in the Saudi population , 2019, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[3]  J. R. Holt,et al.  Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss , 2019, Nature Medicine.

[4]  Shih-Cheng Chang,et al.  Mutation screening in non-syndromic hearing loss patients with cochlear implantation by massive parallel sequencing in Taiwan , 2019, PloS one.

[5]  J. R. Holt,et al.  Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders , 2019, Nature Communications.

[6]  J. R. Holt,et al.  Recessive mutations of TMC1 associated with moderate to severe hearing loss , 2016, neurogenetics.

[7]  J. R. Holt,et al.  TMC1 and TMC2 Localize at the Site of Mechanotransduction in Mammalian Inner Ear Hair Cell Stereocilia. , 2015, Cell reports.

[8]  M. Tekin,et al.  Comprehensive Analysis via Exome Sequencing Uncovers Genetic Etiology in Autosomal Recessive Non-Syndromic Deafness in a Large Multiethnic Cohort , 2015, Genetics in Medicine.

[9]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[10]  K. Kindt,et al.  Tip-link protein protocadherin 15 interacts with transmembrane channel-like proteins TMC1 and TMC2 , 2014, Proceedings of the National Academy of Sciences.

[11]  Ling Yang,et al.  A Novel DFNA36 Mutation in TMC1 Orthologous to the Beethoven (Bth) Mouse Associated with Autosomal Dominant Hearing Loss in a Chinese Family , 2014, PloS one.

[12]  J. R. Holt,et al.  TMC1 and TMC2 Are Components of the Mechanotransduction Channel in Hair Cells of the Mammalian Inner Ear , 2013, Neuron.

[13]  M. Bitner-Glindzicz,et al.  A sensitive and specific diagnostic test for hearing loss using a microdroplet PCR‐based approach and next generation sequencing , 2013, American journal of medical genetics. Part A.

[14]  L. Hickson,et al.  Defining and evaluating success in paediatric cochlear implantation--an exploratory study. , 2012, International journal of pediatric otorhinolaryngology.

[15]  S. Antonarakis,et al.  Tmprss3, a Transmembrane Serine Protease Deficient in Human DFNB8/10 Deafness, Is Critical for Cochlear Hair Cell Survival at the Onset of Hearing* , 2011, The Journal of Biological Chemistry.

[16]  C. Cremers,et al.  Progressive Sensorineural Hearing Loss and Normal Vestibular Function in a Dutch DFNB7/11 Family with a Novel Mutation in TMC1 , 2010, Audiology and Neurotology.

[17]  C. Petit,et al.  Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7/11 , 2008, Clinical genetics.

[18]  A. Tlili,et al.  TMC1 but Not TMC2 Is Responsible for Autosomal Recessive Nonsyndromic Hearing Impairment in Tunisian Families , 2008, Audiology and Neurotology.

[19]  C. Morton,et al.  Newborn hearing screening--a silent revolution. , 2006, The New England journal of medicine.

[20]  C. Meyer,et al.  Novel TMC1 structural and splice variants associated with congenital nonsyndromic deafness in a Sudanese pedigree , 2005, Human mutation.

[21]  A. Griffith,et al.  Early Onset and Rapid Progression of Dominant Nonsyndromic DFNA36 Hearing Loss , 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[22]  H. Ostrer,et al.  Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function , 2002, Nature Genetics.